Editor's Note: Green and red arrows refer to intraday stock price movement.

NEW YORK (

TheStreet

) --

CHANGE IN RATINGS

Arch Capital Group

(ACGL) - Get Report

downgraded at Credit Suisse to Neutral from Outperform as earnings should decline due to continued soft pricing, Credit Suisse said. Maintain $95 price target.

Archer Daniels Midland

(ADM) - Get Report

upgraded at Credit Suisse to Outperform from Neutral as higher and more volatile grain prices will lead to margin expansion, Credit Suisse said. Price target increased to $40 from $37.

American Eagle

(AEO) - Get Report

upgraded at Susquehanna from Neutral to Positive, Susquehanna Financial said. $18 price target.

Axis Capital

(AXS) - Get Report

downgraded at Credit Suisse to Neutral from Outperform due to more cautious view on commercial insurers as pricing remains weak, Credit Suisse said. Maintain $39 price target.

Bunge Limited

(BG) - Get Report

upgraded at Credit Suisse to Outperform from Neutral. Best three year ideas in agribusiness because it is in the early stages of building a platform in sugar, Credit Suisse said. Price target raised to $88 from $65.

Ball

(BLL) - Get Report

downgraded at Goldman from Buy to Neutral, Goldman Sachs said. Valuation call.

BorgWarner

(BWA) - Get Report

downgraded at Credit Suisse to Neutral from Outperform. Valuation call, Credit Suisse said. Price target raised to $73 from $66.

Blackstone

(BX) - Get Report

upgraded at Jefferies from Hold to Buy, Jefferies said. $18.50 price target. Business trends are improving across the board.

CH Robinson

(CHRW) - Get Report

rated new Neutral at Sterne Agee. $76 price target. Company faces potential regulatory challenges.

Clorox

(CLX) - Get Report

downgraded at Barclays to Equal Weight from Overweight. Concerned that in many of CLX's categories, recent innovations have has less sustainable impact on category growth, Barclays said. Maintain $67 price target.

Comerica

(CMA) - Get Report

downgraded at Wells from Outperform to Market Perform, Wells Fargo said. SBIB deal is expensive.

Comerica

(CMA) - Get Report

upgraded at Citigroup from Sell to Hold, Citigroup said. $40 price target. Core credit and loan trends are on the mend.

Comcast

(CMCSA) - Get Report

upgraded at Collins Stewart from Hold to Buy, Collins Stewart said. $32 price target. Company should perform better, now that the NBCU deal has closed.

Cott

(COT) - Get Report

downgraded at Barclays to Equal Weight from Overweight. Valuation call, Barclays said. Maintain $9 price target.

Cypress Semiconductor

(CY) - Get Report

upgraded at UBS from Neutral to Buy, UBS said. $25 price target. Estimates also boosted, based on higher expected demand for TrueTouch controllers.

Dollar Tree

(DLTR) - Get Report

upgraded at Morgan Stanley from Equal-weight to Overweight, Morgan Stanley said. $63 price target. Company can generate double-digit sales growth and has potential operating leverage.

Fastenal

(FAST) - Get Report

downgraded at Piper from Overweight to Neutral, Piper Jaffray said. $62 price target. Company lacks near-term catalysts.

Forest Laboratories

(FRX)

upgraded at JP Morgan from Underweight to Neutral, JP Morgan said. $34 price target. Stock is already pricing in potential generic competition and the company has an attractive pipeline.

Forest Laboratories

(FRX)

numbers increased at Goldman through 2014, Goldman Sachs said. Company can invest its cash into future growth. Neutral rating and new $35 price target.

Fortinet

(FTNT) - Get Report

downgraded at Deutsche from Buy to Hold, Deutsche Bank said. Valuation call, based on a $40 price target.

Google

(GOOG) - Get Report

rated new Hold at ISI Group. $675 price target. Company may struggle to re-accelerate sales growth.

HHGregg

(HGG)

downgraded at Credit Suisse to Neutral from Outperform. Good growth potential, but TV and appliance weakness may continue to weigh on results, Credit Suisse said. Price target trimmed to $22 from $28.

Janus Capital

(JNS)

downgraded at Stifel from Buy to Hold, Stifel Nicolaus said. Company is leveraged to better equity performance.

Linear Technology

(LLTC)

downgraded at Susquehanna from Positive to Neutral, Susquehanna Financial said. Valuation call, based on a $34 price target.

Legg Mason

(LM) - Get Report

downgraded at Stifel from Buy to Hold, Stifel Nicolaus said. Company will not be helped by rising long-term interest rates.

Merck

(MRK) - Get Report

rated new Outperform at Wells Fargo. Company has a solid pipeline and a shallow patent cliff.

Noble Corp.

(NE) - Get Report

downgraded at Deutsche from Buy to Hold, Deutsche Bank said. $40 price target. Increased jackup exposure has added risk to the model.

Annaly Capital

(NLY) - Get Report

downgraded at Jefferies from Buy to Hold, Jefferies said. Investment spreads could contract over the coming quarters. $15 price target.

Pfizer

(PFE) - Get Report

rated new Outperform at Wells Fargo. The company's pipeline is at an inflection point and management is returning cash to shareholders.

Children's Place

(PLCE) - Get Report

upgraded at Susquehanna from Neutral to Positive, Susquehanna Financial said. $54 price target.

Quanta Services

(PWR) - Get Report

upgraded at Sterne Agee from Neutral to Buy, Sterne Agee said. $28 price target. Company should trade back up toward its peers.

RadioShack

(RSH)

downgraded at Credit Suisse to Neutral from Outperform as turnaround merchandising efforts may take longer to bear fruit than expected, Credit Suisse said. Price target cut to $20 from $25.

Spectra Energy

(SE) - Get Report

upgraded at Jefferies from Hold to Buy, Jefferies said. Estimates also upped. $28 price target.

Unifirst

(UNF) - Get Report

downgraded at Baird from Outperform to Neutral, Robert Baird said. Valuation call, based on a $58 price target.

W.R. Berkley Corp

(WRB) - Get Report

downgraded at Credit Suisse to Underperform from Neutral on lower accident year margins due to lower pricing, Credit Suisse said. Maintain $28 price target.

US Steel

(X) - Get Report

downgraded at Deutsche from Buy to Hold, Deutsche Bank said. Valuation call, based on a $57 price target.

This article was written by a staff member of TheStreet.